Spots Global Cancer Trial Database for Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Official Title: Treatment of Breast Fibroadenoma Targeted Tissue With High Intensity Focused Ultrasound (HIFU)
Study ID: NCT03044054
Conditions
Interventions
Study Description
Brief Summary: This study evaluates the efficacy and the safety of the HIFU for the treatment of breast fibroadenoma.
Detailed Description: Echopulse is specially designed, manufactured and CE marked for treating breast fibroadenoma. HIFU is a completely alternative to surgery which utilizes high-energy ultrasound to deliver a large amount of sound energy to a focal point to rapidly induce tissue heating to 85-90°C.This initiates tissue coagulation followed by tissue necrosis ablating the targeted area.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Bellevue Hospital Center, New York, New York, United States
New York Columbia University Medical Center, New York, New York, United States
Montefiore-Einstein Center for Cancer Care, New York, New York, United States
University of Virginia Health system, Charlottesville, Virginia, United States
Contact Details
Name: Michel NUTA, MD
Affiliation: Theraclion
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
